Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ALRM
51 Biggest Movers From Yesterday
Benzinga's Option Alert Recap From October 25
Related PYPL
Wall Street Weighs In: Two Analyst's Favorite Stocks In The Payments Space
One Big Reason Why Tech Stocks Are Not In The 'Dot-Com Bubble'
' Stocks Moving Wednesday (GuruFocus)

Imperial Capital initiated coverage on AlarmCom Hldg Inc (NASDAQ: ALRM) with a Outperform rating. The target price for AlarmCom is set to $23. AlarmCom shares closed at $18.00 yesterday.

Analysts at Barclays initiated coverage on Paypal Holdings Inc (NASDAQ: PYPL) with a Overweight rating. The target price for Paypal Holdings is set to $47. Paypal Holdings shares closed at $39.35 yesterday.

Analysts at Brean Capital initiated coverage on Perry Ellis International, Inc. (NASDAQ: PERY) with a Buy rating. The target price for Perry Ellis is set to $30. Perry Ellis shares closed at $23.37 yesterday.

Analysts at Chardan Capital initiated coverage on Applied Genetic Technologies Corp (NASDAQ: AGTC) with a Buy rating. The target price for Applied Genetic Technologies is set to $25. Applied Genetic Technologies shares closed at $18.48 yesterday.

CLSA initiated coverage on WestRock Co (NYSE: WRK) with a Underperform rating. The target price for WestRock is set to $65. WestRock shares closed at $59.85 yesterday.

Analysts at Roth Capital initiated coverage on Lipocine Inc (NASDAQ: LPCN) with a Buy rating. Lipocine shares closed at $11.79 yesterday.

Analysts at Canaccord Genuity initiated coverage on Seres Therapeutics Inc (NASDAQ: MCRB) with a Buy rating. The target price for Seres Therapeutics is set to $50. Seres Therapeutics shares closed at $39.16 yesterday.

Analysts at Northland Securities initiated coverage on Juno Therapeutics Inc (NASDAQ: JUNO) with a Outperform rating. The target price for Juno Therapeutics is set to $64. Juno Therapeutics shares closed at $50.10 yesterday.

B. Riley initiated coverage on Ciena Corporation (NYSE: CIEN) with a Buy rating. The target price for Ciena is set to $30.75. Ciena shares closed at $25.53 yesterday.

Roth Capital initiated coverage on Pieris Pharmaceuticals Inc (NASDAQ: PIRS) with a Buy rating. The target price for Pieris Pharmaceuticals is set to $7. Pieris Pharmaceuticals shares closed at $2.70 yesterday.

Latest Ratings for ALRM

DateFirmActionFromTo
Nov 2017Credit SuisseMaintainsOutperform
Oct 2017Bank of AmericaMaintainsBuy
Oct 2017Bank of AmericaMaintainsBuy

View More Analyst Ratings for ALRM
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AGTC + ALRM)

View Comments and Join the Discussion!

Partner Center